These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2181099)

  • 1. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.
    Cimolai N; Carter JE; Morrison BJ; Anderson JD
    J Pediatr; 1990 Apr; 116(4):589-92. PubMed ID: 2181099
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.
    Safdar N; Said A; Gangnon RE; Maki DG
    JAMA; 2002 Aug; 288(8):996-1001. PubMed ID: 12190370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.
    Gill CJ; Hamer DH; Lau J
    JAMA; 2002 Dec; 288(24):3110-1; author reply 3112. PubMed ID: 12495387
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.
    Wong CS; Brandt JR
    JAMA; 2002 Dec; 288(24):3111; author reply 3112. PubMed ID: 12495388
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.
    Tarr PI; Watkins SL; Neill MA
    JAMA; 2002 Dec; 288(24):3111-2; author reply 3112. PubMed ID: 12495389
    [No Abstract]   [Full Text] [Related]  

  • 7. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
    Wong CS; Jelacic S; Habeeb RL; Watkins SL; Tarr PI
    N Engl J Med; 2000 Jun; 342(26):1930-6. PubMed ID: 10874060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.
    Proulx F; Turgeon JP; Delage G; Lafleur L; Chicoine L
    J Pediatr; 1992 Aug; 121(2):299-303. PubMed ID: 1640303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
    O'Ryan M; Prado V
    N Engl J Med; 2000 Oct; 343(17):1271; author reply 1272-3. PubMed ID: 11183358
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
    Aragón T; Fernyak S; Reiter R
    N Engl J Med; 2000 Oct; 343(17):1271-2; author reply 1272-3. PubMed ID: 11183357
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.
    Bell BP; Griffin PM; Lozano P; Christie DL; Kobayashi JM; Tarr PI
    Pediatrics; 1997 Jul; 100(1):E12. PubMed ID: 9200386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection.
    Mølbak K; Mead PS; Griffin PM
    JAMA; 2002 Aug; 288(8):1014-6. PubMed ID: 12190374
    [No Abstract]   [Full Text] [Related]  

  • 13. E. coli, antibiotics and hemolytic-uremic syndrome in children.
    Farquhar D
    CMAJ; 2000 Aug; 163(4):438. PubMed ID: 10976267
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.
    Pavia AT; Nichols CR; Green DP; Tauxe RV; Mottice S; Greene KD; Wells JG; Siegler RL; Brewer ED; Hannon D
    J Pediatr; 1990 Apr; 116(4):544-51. PubMed ID: 2181098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.
    Griffin PM; Ostroff SM; Tauxe RV; Greene KD; Wells JG; Lewis JH; Blake PA
    Ann Intern Med; 1988 Nov; 109(9):705-12. PubMed ID: 3056169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
    Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
    Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.
    Neill MA; Tarr PI; Clausen CR; Christie DL; Hickman RO
    Pediatrics; 1987 Jul; 80(1):37-40. PubMed ID: 3299236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antibiotic therapy of mice and humans useful in Escherichia coli O157:H7 enteritis?
    Proulx F; Seidman E
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):533-4. PubMed ID: 10517188
    [No Abstract]   [Full Text] [Related]  

  • 19. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.
    Tarr PI; Neill MA; Clausen CR; Watkins SL; Christie DL; Hickman RO
    J Infect Dis; 1990 Aug; 162(2):553-6. PubMed ID: 2197346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimotility agents and E. coli infection.
    Tarr PI; Christie DL
    CMAJ; 1999 Apr; 160(7):984, 986. PubMed ID: 10207332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.